ArticleCureus2026
Improving the Quality of Life of Breast Cancer Chemotherapy Patients With Egg Protein Supplementation: Evidence From an Experimental Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is the most frequently diagnosed cancer in women around the globe; both cancer and its treatment influence breast cancer patients' food intake behaviors and quality of life (QoL). Standard egg protein was supplemented to breast cancer chemotherapy patients, and QoL was assessed.
methodsA total of 63 breast cancer chemotherapy patients were included in the study. The QoL Questionnaire (EORTC QLQ-30, Version-3) of the European Organization for Research and Treatment of Cancer (EORTC) was used to measure the QoL. The Intervention Group (n=33) received one whole boiled egg and two boiled egg whites per day for 12 weeks, while the Control Group did not. Socioeconomic and cancer-related data, dietary intake, anthropometric measurement (height, weight), biochemical indices (WBC, RBC, platelet count, serum glutamic-pyruvic transaminase (SGPT), serum glutamic-oxaloacetic transaminase (SGOT), serum creatinine, and albumin), and QoL data were collected at three timelines (Baseline, Follow-up at six weeks, and Endline after 12 weeks).
resultsMean quality of life scores increased from baseline (3.8, 95%CI: 3.5-4.1) to the endline (4.48, 95%CI: 4.3-4.8) in the Intervention Group, while those decreased in the Control Group (n=30) from 4.6 (95%CI: 4.3-4.9) to 3.8 (95%CI: 3.4-3.9). However, weight gain was static (P>0.05) for cases, despite the Control Group losing weight significantly across the three timelines (P=0.03). The biochemical profile revealed that time-dependent increments of lymphocytes, monocytes, eosinophils, and albumin levels occurred only in the Intervention Group (P < 0.05), while insignificant changes were observed in the Control Group across the timelines (P > 0.05). Multivariate analysis of covariance (MANCOVA) revealed that last week's health-activity score (P<0.001), BMI (P=0.003), calorie intake/day (P=0.015), and egg-protein intake/day (P=0.047) were significant time-varying predictors associated with QoL scores. Conversely, non-time-dependent predictors (socioeconomic and cancer-related variables) were found to be insignificant.
conclusionImproved QoL scores in the intervention group strongly correlated with the immunonutritional influence of standard egg protein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.